Skip to content

Bupropion

NDRI • Brands: Wellbutrin

Last reviewed: 2025-09-23

General information

Indicated for: Bupropion hydrochloride extended-release tablets (SR) are an aminoketone antidepressant, indicated for the treatment of major depressive disorder (MDD). ( 1 )

Dosing & forms

  • Forms/strengths:
  • Frequency:
  • Food:
  • Typical range: 150–450 mg/day (IR/SR/XL)

Mechanism (brief)

Norepinephrine–dopamine reuptake inhibitor (NDRI).

Metabolism & Half‑life

  • Metabolism: CYP2B6, active metabolites.
  • Half‑life: ~21 h (parent).

Therapeutic Drug Monitoring (TDM)

Recommended: No

View labelExact

Monitoring highlights

Sources